Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825300 · ClinicalTrials.gov registry record · NA
Encouraging Blood Donation in Patients With a Blood Type in Short Supply - Part 2
A NA study of Behavior, Health, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40,486
- Enrollment target
- 1
- Study location
NCT05825300: Completed NA study of Behavior, Health, sponsored by Geisinger Clinic.
NCT05825300 is a NA study of Behavior, Health that has completed, run by Geisinger Clinic. The registered enrollment target is 40,486 participants, above the 13,767-participant average among 20 other Behavior, Health trials with a reported enrollment target (194% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05825300, a NA study of Behavior, Health, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40,486 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test whether emails that inform patients they have a blood type in need are more effective at encouraging patients to schedule and attend blood donation appointments, compared to email messages that do not mention the patient has a blood type in need.
Primary Outcome
Attended a donation appointment within 6 weeks of their message send date, regardless of whether they donated. This outcome includes patients who were unable to donate for any reason (e.g., low hemoglobin) or patients who showed up to the appointment but decided to leave before donating.
Conditions Studied
Interventions
- BEHAVIORAL Email message
- BEHAVIORAL Social responsibility
Study Locations (1)
Pennsylvania
- Geisinger Clinic - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,486 participants |
| Start Date | 2023-04-10 |
| Est. Completion | 2023-07-03 |
| Phase | NA |
What the finished NCT05825300 record still lists
NCT05825300 is an interventional study that assigns participants to a tested intervention. Its 40,486 participants enrollment target places it among the larger protocols in the corpus, above the 13,767-participant average among 20 other Behavior, Health trials with a reported enrollment target (194% higher).
The record links to 1 condition, with Behavior, Health appearing as the primary indexed condition, and to 2 interventions - of which Email message is the first listed.
NCT05825300 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05825300 about?
NCT05825300 is a clinical study titled "Encouraging Blood Donation in Patients With a Blood Type in Short Supply - Part 2". The goal of this study is to test whether emails that inform patients they have a blood type in need are more effective at encouraging patients to schedule and attend blood donation appointments, compared to email messages that do not mention the patient has a blood type in need.
What is the current status of trial NCT05825300?
This trial is currently completed. It is a NA study. The enrollment target is 40,486 participants. The study started on 2023-04-10. Estimated completion is 2023-07-03.
What conditions does trial NCT05825300 study?
This clinical trial studies the following conditions: Behavior, Health.
What interventions are being tested in trial NCT05825300?
The interventions under investigation include: Email message (BEHAVIORAL), Social responsibility (BEHAVIORAL).
Who is sponsoring clinical trial NCT05825300?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825300 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior, Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05825300's enrollment target sits among peer trials
40,486 2nd of 20 the highest of 20 other Behavior, Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Fit With Us Study
RECRUITING · NA
-
Parent-Child Memory Study: Improving Future Thinking Among Mothers
RECRUITING · NA
-
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
RECRUITING · NA
-
Game-based Pediatric Diabetes Education
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Improving Congenital Heart Disease Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI